Sudair Pharma Achieves “Saudi Made” Golden Tier Classification

Sudair Pharma has been awarded the prestigious Saudi Made Golden Tier classification, recognizing the company’s exceptional contribution to national localization efforts, investment in Saudi talent, and utilization of locally sourced materials in pharmaceutical manufacturing.
Sudair Pharma proudly announces its achievement of the Saudi Made Golden Tier classification—one of the highest recognitions granted to national companies that demonstrate outstanding commitment to localization, innovation, and national manufacturing standards.
 
This milestone reflects Sudair Pharma’s strong alignment with the goals of Saudi Vision 2030, particularly in strengthening pharmaceutical security, empowering national talent, and increasing the contribution of local materials and suppliers across the company’s manufacturing value chain.
 
Supporting National Capabilities
 
The Golden Tier classification highlights Sudair Pharma’s consistent efforts to:
 
Invest in Saudi talent development, training programs, and job creation within advanced pharmaceutical industries.
 
Expand the use of locally sourced materials and components in drug production.
 
Strengthen partnerships with national suppliers to grow local manufacturing ecosystems.
 
Advance research and innovation within the Kingdom to improve the quality and competitiveness of Saudi-made pharmaceutical products.
 
Commitment to Localization and Competitiveness
 
This recognition underscores Sudair Pharma’s role as a key enabler in the localization of critical pharmaceutical products, positioning the company as a national leader in modern drug manufacturing and a contributor to achieving long-term healthcare independence.
 
Sudair Pharma remains committed to expanding its capabilities, advancing local industry standards, and increasing the global presence of Saudi-made pharmaceutical products.